## **Core Concept**
Hypercalcemia in lung cancer is primarily associated with the production of **parathyroid hormone-related protein (PTHrP)** or other factors that mimic the action of parathyroid hormone (PTH), leading to increased calcium levels in the blood. This condition is a well-recognized paraneoplastic syndrome.

## **Why the Correct Answer is Right**
The correct answer, **Squamous cell carcinoma**, is right because this type of lung cancer is most commonly associated with the production of **PTHrP**. PTHrP causes hypercalcemia by increasing osteoclast activity (and thus bone resorption), decreasing renal calcium excretion, and increasing calcium absorption in the gut indirectly. Squamous cell carcinoma of the lung is notorious for causing hypercalcemia through this mechanism.

## **Why Each Wrong Option is Incorrect**
- **Option A: Small cell carcinoma** is incorrect because, although it can cause various paraneoplastic syndromes, it is less commonly associated with hypercalcemia compared to squamous cell carcinoma. When hypercalcemia does occur, it's often due to **PTHrP** production but is more rare.
- **Option B: Adenocarcinoma** is incorrect because, while it is the most common type of lung cancer, it is less frequently associated with hypercalcemia compared to squamous cell carcinoma.
- **Option C: Large cell carcinoma** is incorrect as it is not specifically known for causing hypercalcemia through **PTHrP** production as commonly as squamous cell carcinoma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **squamous cell carcinoma of the lung** is a classic cause of **hypercalcemia of malignancy** due to **PTHrP** production. This association is a high-yield fact for exams and clinical practice, helping to guide the differential diagnosis for hypercalcemia.

## **Correct Answer: C. Squamous cell carcinoma**